n.beaulieu
Submits third-party assay reports on material purchased directly. Based in Zaragoza.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.03%
n=9
Suppliers covered
8
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043610 | BPC-157 | BCH | BCH-2603-G6533 | Janoshik | 2026-Q3 | 98.69 | 4.75 | 90.2 | Buyer-sourced | 0 | PASS |
| AX-2026-041689 | Survodutide | QSC | QSC-2509-E9197 | VendorInvestigate | 2026-Q1 | 99.03 | 5.30 | 103.2 | Buyer-sourced | 0 | PASS |
| AX-2026-042644 | Melanotan II | SWB | SWB-2602-J6944 | Kestrel | 2026-Q1 | 99.83 | 4.61 | 99.0 | Buyer-sourced | 0 | PASS |
| AX-2025-020791 | Semaglutide | GL Biochem | GLBI-2508-D9127 | Medutest | 2025-Q4 | 98.80 | 3.92 | 107.2 | Buyer-sourced | 0 | PASS |
| AX-2025-020801 | Ipamorelin | SGN | SGN-2502-W9115 | Nordanalyt | 2025-Q2 | 98.88 | 1.83 | 99.0 | Buyer-sourced | 1 | FAIL |
| AX-2025-019310 | Semaglutide | TFC | TFC-2502-L7660 | VendorInvestigate | 2025-Q1 | 98.48 | 3.22 | 95.7 | Buyer-sourced | 0 | PASS |
| AX-2025-019735 | Tirzepatide | HJ | HJ-2501-P3891 | Kestrel | 2025-Q1 | 99.25 | 2.60 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019360 | Afamelanotide | TFC | TFC-2502-Y7905 | Medutest | 2025-Q1 | 99.55 | 5.38 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004833 | PT-141 (Bremelanotide) | Homopeptide | HOMO-2408-P1394 | Janoshik | 2024-Q4 | 99.65 | 1.95 | 90.0 | Buyer-sourced | 0 | PASS |
| Supplier | Records | Median purity |
|---|---|---|
| TFC | 2 | n<3 |
| BCH | 1 | n<3 |
| QSC | 1 | n<3 |
| SWB | 1 | n<3 |
| GL Biochem | 1 | n<3 |
| SGN | 1 | n<3 |
| HJ | 1 | n<3 |
| Homopeptide | 1 | n<3 |